Detection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia
Cüneyt Ünsal,1 Mustafa Oran,2 Hande Oktay Tureli,3 Seref Alpsoy,4 Sema Yesilyurt,5 Mehtap Arslan,6 Birol Topcu,7 Osman Karakaya,8 Erhan Kurt6 1Department of Psychiatry, Namik Kemal University, School of Medicine, Tekirdag, Turkey; 2Department of Internal Medicine, Namik Kemal Unive...
Enregistré dans:
Auteurs principaux: | Ünsal C, Oran M, Tureli HO, Alpsoy S, Yeşilyurt S, Arslan M, Topcu B, Karakaya O, Kurt E |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/26ad6cd5655e47e3bce65dd42b057810 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
par: Ünsal C, et autres
Publié: (2013) -
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis
par: Peluso R, et autres
Publié: (2019) -
A Nomogram for Identifying Subclinical Atherosclerosis in Chronic Kidney Disease
par: Xiong J, et autres
Publié: (2021) -
Subclinical Left Ventricular Dysfunction During Chemotherapy
par: Martin Nicol, et autres
Publié: (2019) -
Factors for remodeling and diastolic myocardial dysfunction in postmenopausal women with diabetes and hypertension
par: O S Elsukova, et autres
Publié: (2013)